We are passionate about patient quality.
Our Director of Patient Care is primarily responsible for the provision of expert clinical guidance to our Trust Board and for establishing and quality assuring appropriate standards of care and clinical governance. The Director is responsible for setting the standards of clinical practice and underpinning educational and training levels required to achieve those the Trust operates to and assuring our Corporate Board of our compliance to those standards.
- the provision of strong clinical leadership at all levels throughout the Trust
To ensure the Trust has the clinical capacity to provide safe reliable care for its patients
- to establish appropriate standards of clinical care and ensure they are communicated and understood by all staff responsible for delivering care
To ensure systems are in place to monitor delivery for clinical care across all areas of Trust activity
- to contribute to the development and implementation of alternative models of clinical care to meet the diverse needs of patients
- to ensure the Trust Board understands its statutory duties in respect of patient care and takes action to ensure these duties are met
Care Quality Commision
We are regulated by the Care Quality Commission (CQC).
The Care Quality Commission website shows a summary of whether this service is meeting the essential standards of safety and quality.
If a service is meeting all standards it will show a tick; if a service is not meeting one standard or more, it will show a cross and an explanation that the CQC require improvements or are taking enforcement action.
You can see our full profile page on the CQC website at http://www.cqc.org.uk/directory/rye
The Trust is committed to minimising all risks associated with infection control and reducing the impact of healthcare associated infection on patients staff and the organisation overall. The Trust encourages the open reporting of infection incidents and risks as part of its adverse incident reporting procedures
The Infection, prevention control and decontamination policy covers all the aspects of infection control and decontamination that are required to protect all staff, patients and third parties, and those issues and procedures raised by Assurance framework or required for statutory purposes
You can also view our Director of Infection Prevention and Control Annual Report 2018-19.
South Central Ambulance Service NHS Foundation Trust’s SCAS Clinical strategy ‘Future opportunities’ * presents our exciting vision for the services we provide and, importantly, work is already taking place to turn this vision into reality. We are driven by one overarching ambition, which is to deliver the best possible service to our patients.
Our aims are to:
- provide the best care in all our services
- provide care based on the patient’s individual needs
- make it easier, as well as quicker, to access emergency and urgent care
- to get the right balance between highly specialist care where it is needed and more local care where appropriate
- play our role in encouraging healthier communities and individuals.
The SCAS Clinical strategy ‘Future opportunities’ * helps us and our teams to understand the agenda we face going forward. Quality is always going to be a key priority for our services, to deliver quality will mean us working differently – focusing on patients and their health needs, working across pathways and working with other clinical colleagues. Our staff are close to our patients, so can see how they can change things to make them better for them. We look forward to working with you to provide the safe and high quality care for our communities.
This strategy has been developed by working closely with internal colleagues and has been consulted on with key stakeholders. Their comments have been considered, and where appropriate, incorporated into the document. A common theme from discussions is that partner agencies have commented on us being involved in taking forward both short term Quality, Innovation, Productivity and Prevention projects as well as having an active part in the longer term transformational change programmes. Such work includes active participation and contribution to urgent care boards and clinician to clinician dialogue. We recognise that we have a role to play in influencing the strategy of partner organisation.
Clinical Quality Governance Strategy
The purpose of the Clinical and quality governance strategy * is to establish and to provide assurance that robust systems are being embedded into the organisation to address national and local clinical and quality governance requirements. These need to continue to be progressed and are key to the transition of the Trust being a clinically led organisation over the next 2 years, and in the shorter term, over the period leading to application for Foundation Trust.
However, this is a long-term strategy and is dynamic and it will need to be reviewed bi-annually and adapted to meet future local needs of the Trust (given the changing Healthcare landscape as outlined within Liberating the NHS Equity and Excellence, DH 2010); this will in turn have an effect on the future local needs of trusts.
Annual Quality Report
The Trust Board is fully engaged with improving quality in our organisation and undertake regular leadership walkarounds. The Board will robustly monitor and scrutinise emerging risks to quality standards via the integrated performance report and measures.
Throughout the development of this report we have involved our staff and clinical teams, Health Overview and Scrutiny Committees (HOSCs), our NHS commissioners and our governors and members.
Declaration of Single Sex Accommodation
Joint Royal Colleges Ambulance Liaison Committee
The Joint Royal Colleges Ambulance Liaison Committee (JRCALC) develops national clinical practice guidelines for NHS paramedics. The Clinical Guidelines have been adopted by South Central Ambulance Service and form the basis for UK paramedic training and education. The guidelines are reviewed on a five year cycle and are developed or updated, based on systematic reviews of the evidence and consensus agreement. To access the JRCALC clinical practice guidelines click here.